What Happened
- Following the US Supreme Court's invalidation of IEEPA-based tariffs on February 20, 2026, the Trump administration invoked Section 122 of the Trade Act of 1974 to impose a new temporary 15% global import surcharge, effective from February 24, 2026, for 150 days.
- The new 15% universal levy overrides the interim tariff framework for India, under which Trump had slashed reciprocal duties from 25% to 18% through an executive arrangement; Indian goods will now face a 15% flat surcharge rather than the 18% reciprocal duty.
- The India-US Bilateral Trade Agreement (BTA) talks remain on course — Commerce Minister Piyush Goyal confirmed the deal may be signed in March and become effective from April 2026.
- An Indian negotiating team led by chief negotiator Darpan Jain was scheduled to meet US counterparts in Washington from February 23-26 to finalise the legal text for Phase 1 of the agreement; the visit was subsequently rescheduled pending internal government assessments.
- The Supreme Court ruling nullified the legal basis for the 18% reciprocal duties India faced under the unsigned interim trade framework, effectively moving the goalposts for the ongoing negotiations.
Static Topic Bridges
India-US Bilateral Trade Agreement (BTA) — Structure and Significance
India and the US announced an intent to negotiate a comprehensive Bilateral Trade Agreement (BTA) following the Modi-Trump summit in February 2025. The BTA is structured in phases: Phase 1 (an interim agreement) would deliver early tariff concessions on select goods, with subsequent phases covering broader market access, intellectual property, data flows, and services. The interim deal announced in early February 2026 envisaged the US cutting reciprocal tariffs on India from 25% to 18%, while India offered concessions including zero duty on generic pharmaceuticals.
- India-US bilateral trade (2024-25): approximately $191 billion (India's largest bilateral trade partner)
- India's trade surplus with the US: approximately $45 billion — the primary trigger for US pressure
- Interim deal framework: US reciprocal tariff on India 25% → 18%; India to offer zero duty on generic pharma and reduce tariffs on select goods
- Post-Section 122 situation: India faces a 15% flat global surcharge (replacing the 18% reciprocal structure) — a marginal improvement for Indian exporters
- BTA differs from FTA: FTAs have permanent tariff schedules; the BTA/interim deal is a political framework subject to ongoing negotiation and ratification
- The deal, once finalised, would be the first substantive trade agreement between India and the US since the lapse of India's GSP (Generalised System of Preferences) benefits in 2019
Connection to this news: The Section 122 tariff partially overrides the interim deal's tariff architecture, but both governments have signalled the broader BTA negotiations will continue, with March-April 2026 as the target timeline.
India's Trade Policy Framework — MFN, Tariff Bindings, and Preferential Agreements
India's tariff policy operates within the WTO framework of Most Favoured Nation (MFN) rates — the standard duties applied to all WTO members absent a preferential agreement. India's average bound tariff (the ceiling India has committed to at WTO) is around 48.5% for agricultural goods and 34.6% for non-agricultural goods; applied MFN rates are generally lower. The US Section 122 surcharge is applied on top of existing MFN rates, raising the total duty burden on Indian exports.
- India's key export sectors to the US: pharmaceuticals, textiles and garments, engineering goods, IT services (not covered by goods tariffs), gems and jewellery, chemicals
- GSP (Generalised System of Preferences): India was the largest beneficiary until the US withdrew India's GSP benefits in June 2019 under Trump's first term; not yet restored
- WTO Dispute Settlement: India could potentially challenge unilateral US tariffs at the WTO, but the US has blocked WTO Appellate Body appointments since 2019, rendering the appeals mechanism dysfunctional
- India's current trade agreements: CEPA with UAE (2022), TEPA with Australia (2023 interim deal), FTA negotiations ongoing with EU, UK, Canada, and now the US BTA
Connection to this news: The Section 122 surcharge adds to the cumulative tariff burden on Indian goods (MFN + surcharge), increasing urgency for a finalised BTA that would negotiate India-specific rates rather than being subject to blanket global orders.
Presidential Trade Authority in the US — Constitutional and Statutory Framework
The US Constitution vests the power to regulate foreign commerce and levy tariffs in Congress (Article I, Section 8). Congress has, over decades, delegated trade authority to the President through specific statutes, each with defined scope and conditions. The Supreme Court's February 2026 ruling narrows this delegation by holding that IEEPA's "regulate" language does not implicitly include tariff-setting.
- Key presidential trade authority statutes: Section 201 (Trade Act 1974 — safeguards), Section 232 (Trade Expansion Act 1962 — national security tariffs), Section 301 (Trade Act 1974 — unfair trade practices), Section 122 (Trade Act 1974 — balance of payments)
- Section 232 tariffs on steel and aluminium continue unaffected by the ruling
- Section 122 is time-limited (150 days maximum without Congressional extension), making the current 15% surcharge a temporary measure requiring either Congressional action or executive invocation of another authority by approximately July 2026
- WTO consistency: Unilateral US surcharges violate WTO MFN obligations; the US has invoked GATT Article XXI (national security exception) to justify Section 232 tariffs, but Section 122 balance-of-payments justification is contested under GATT Article XII/XVIII
Connection to this news: The constrained and time-limited nature of Section 122 authority creates a negotiating window for India — the BTA, if concluded before the 150-day expiry, would lock in preferential treatment before Congress or the executive must act again.
Key Facts & Data
- Section 122 surcharge rate: 15% (maximum permitted under the statute)
- Duration: 150 days from February 24, 2026 (expires approximately July 23, 2026)
- Requires Congressional action to extend beyond 150 days
- India's current tariff exposure to US: 15% Section 122 surcharge + existing MFN tariffs
- Previous tariff trajectory: 50% (initial reciprocal) → 25% (after Modi-Trump summit) → 18% (interim deal) → 15% (Section 122 flat rate)
- India-US bilateral goods trade: approximately $191 billion (FY 2024-25)
- India's trade surplus with the US: approximately $45 billion
- India's GSP benefits lapsed: June 2019; not restored as of 2026
- BTA Phase 1 target signing: March 2026; operationalisation: April 2026
- Indian negotiation team: led by chief negotiator Darpan Jain